1. /
  2. Our work /
  3. Projects /
  4. Eliminating hepatitis C infection in Australia through harm reduction, education and treatment scale up
Projects

Eliminating hepatitis C infection in Australia through harm reduction, education and treatment scale up

Open to students

Hepatitis C affects over 230,000 people in Australia. Currently only 1 to 2 per cent of people with chronic HCV are treated annually. In 2016, the World Health Organization set targets to reduce new HCV infections by 80 per cent, reduce deaths due to HCV by 65 per cent, and eliminate HCV as a public health problem by 2030.

With new, effective non-interferon-based treatments, it should be possible for Australia to achieve these elimination targets. Key to our success in reducing HCV-related deaths and new infections in Australia will be the upscaling of treatment for all people with chronic HCV infection, including those currently transmitting HCV who are chiefly people who inject drugs. New community-based treatment programs in primary care, drug and alcohol services and community organisations are being rolled out locally.

This project is open to students

View 57 more

Improve the quality of care

The project will aim to explore:

  • improved harm reduction strategies
  • workforce development and health service delivery
  • supports needed for prescribers to start treatment.

The outcomes will help facilitate treatment uptake and improve the quality of care.

Open to
  • Honours
  • Masters by research
  • PhD
Supervisors
Contact

Project contacts

Professor Joseph (Joe) Doyle

Professor Joseph (Joe) Doyle

Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow
joseph.doyle@burnet.edu.au
View profile

Project team

Professor Joseph (Joe) Doyle

Professor Joseph (Joe) Doyle

Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow
View profile

More student projects

View 55 more
Young people’s health in Australia: statistics from the Sex, Drugs and Rock ‘n’ Roll survey
Open to students

Young people’s health in Australia: statistics from the Sex, Drugs and Rock ‘n’ Roll survey

Every year, we survey young people about their sexual health, drug use, mental health and wellbeing. That data informs public health policies and programs.

Impact of malaria and other host factors on COVID-19 immune responses following infection and vaccination
Open to students

Impact of malaria and other host factors on COVID-19 immune responses following infection and vaccination

Understanding immune development to the COVID-19 virus (SARS-CoV-2) in areas of high malaria transmission will inform future COVID-19 control strategies and underlying immune development.

Hepatitis B modelling
Open to students

Hepatitis B modelling

We use mathematical and economic models to inform global efforts to achieving the elimination of hepatitis B as a public health threat.

View 55 more
L3 MEETINGROOM2 0406 Cropped

Why study at Burnet?

When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.

Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.

Find out more Student projects

Study at Burnet

Broaden your impact

On this page